Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
July 25, 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
July 25, 2024 07:00 ET
|
AC Immune SA
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease Treatment of first randomized person with preclinical AD expected this quarterPhase 2b ReTain...
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
July 25, 2024 07:00 ET
|
Predictive Oncology Inc.
Expands AI/ML driven offering to include novel oncology biomarker discovery to predict patient outcomes and drug response in oncology Biomarker discovery market estimated by third party research to...
Ultralife Corporation Reports Second Quarter Results
July 25, 2024 07:00 ET
|
Ultralife Corporation
NEWARK, N.Y., July 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2024 with the following highlights: Sales of...
Silvaco Announces Date of Second Quarter 2024 Financial Results Conference Call
July 25, 2024 07:00 ET
|
Silvaco
SANTA CLARA, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital...
American Airlines Reports Second-Quarter 2024 Financial Results
July 25, 2024 07:00 ET
|
American Airlines, Inc.
FORT WORTH, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its second-quarter 2024 financial results, including: Highest-ever quarterly revenue...
ConnectOne Bancorp, Inc. Reports Second Quarter 2024 Results; Declares Common and Preferred Dividends
July 25, 2024 07:00 ET
|
ConnectOne Bancorp, Inc.
ENGLEWOOD CLIFFS, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net...
First Northwest Bancorp Reports Second Quarter 2024 Financial Results
July 25, 2024 07:00 ET
|
First Northwest Bancorp
First Northwest Bancorp Reports Second Quarter 2024 Financial Results
PLBY Group to Report Second Quarter 2024 Financial Results on August 8, 2024
July 25, 2024 07:00 ET
|
PLBY Group, Inc.
LOS ANGELES, July 25, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...
Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis
July 25, 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab reported positive topline results from Ph 2 trial assessing CM-101 in PSC. Achieved safety endpoint and improved wide range of secondary endpoints